(Q37049981)

17 August 2017

1 reference

title

Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients (English)

1 reference

17 August 2017

author name string

Lawrence F Eichenfield

1

1 reference

17 August 2017

Diamant Thaci

2

1 reference

17 August 2017

Yves de Prost

3

1 reference

17 August 2017

Lluis Puig

4

1 reference

17 August 2017

Carle Paul

5

1 reference

17 August 2017

publication date

17 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

215 Suppl 1

1 reference

17 August 2017

page(s)

3-17

1 reference

Atopic dermatitis: new insights and opportunities for therapeutic intervention

17 August 2017

cites work

1 reference

The Infants' Dermatitis Quality of Life Index.

21 January 2018

1 reference

Atopic dermatitis and the atopic march

21 January 2018

1 reference

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

21 January 2018

1 reference

Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus

21 January 2018

1 reference

Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells

21 January 2018

1 reference

Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids

21 January 2018

1 reference

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

21 January 2018

1 reference

Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis

21 January 2018

1 reference

Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

21 January 2018

1 reference

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants

21 January 2018

1 reference

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

21 January 2018

1 reference

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

21 January 2018

1 reference

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

21 January 2018

1 reference

Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.

21 January 2018

1 reference

Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants

21 January 2018

1 reference

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.

21 January 2018

1 reference

Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.

21 January 2018

1 reference

Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years

21 January 2018

1 reference

A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis

21 January 2018

1 reference

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies

21 January 2018

1 reference

First experience of topical SDZ ASM 981 in children with atopic dermatitis

21 January 2018

1 reference

Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study

21 January 2018

1 reference

Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination

21 January 2018

1 reference

Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hairless mouse epidermis

21 January 2018

1 reference

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

21 January 2018

1 reference

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

21 January 2018

1 reference

New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000102116

1 reference

17 August 2017

1 reference